IVY Network-led study endorses RSV vaccine for older adults

A recent study led by the IVY Network validated the RSV vaccine for older adults. The findings are reported in an article by Craig Boerner on Vanderbilt University Medical Center’s website.

The study aimed to find the length of time a dose of the vaccine remains effective for protecting against the virus. Ultimately, an RSV vaccine dose reduced hospitalization risk in older adults for two seasons. The authors recommend continued surveillance to determine if redosing patients is necessary and when.